Cargando…
NR4A2 may be a potential diagnostic biomarker for myocardial infarction: A comprehensive bioinformatics analysis and experimental validation
BACKGROUND: Myocardial infarction is a well-established severe consequence of coronary artery disease. However, the lack of effective early biomarkers accounts for the lag time before clinical diagnosis of myocardial infarction. The present study aimed to predict critical genes for the diagnosis of...
Autores principales: | Wei, Dongsheng, Qi, Jiajie, Wang, Yuxuan, Li, Luzhen, Yang, Guanlin, He, Xinyong, Zhang, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815548/ https://www.ncbi.nlm.nih.gov/pubmed/36618351 http://dx.doi.org/10.3389/fimmu.2022.1061800 |
Ejemplares similares
-
Bioinformatics analysis to screen for genes related to myocardial infarction
por: Yang, Liting, et al.
Publicado: (2022) -
Bioinformatics prediction and experimental verification of a novel microRNA for myocardial fibrosis after myocardial infarction in rats
por: Guo, Qianqian, et al.
Publicado: (2023) -
NR4A2 protects cardiomyocytes against myocardial infarction injury by promoting autophagy
por: Liu, Honghong, et al.
Publicado: (2018) -
Comprehensive assessment of NR ligand polypharmacology by a multiplex reporter NR assay
por: Medvedev, Alexander, et al.
Publicado: (2022) -
The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset
por: Liu, Weidong, et al.
Publicado: (2022)